Study described how cases of all types of mosquito-borne diseases are increasing in Europe.
Critics say U.K. decision on ALS drug could have ‘chilling effect’ on access to new genetic medicines
LONDON — Neurologists and patient advocates are up in arms over a policy decision by a U.K. health agency that they say will imperil access